Combining lifestyle changes with medication may help control symptoms of overactive bladder. A 2020 clinical trial suggested that combining behavioral therapy with pharmaceutical treatment ...

A number of reports have suggested that the use of prolonged antibiotic treatment could be an effective therapy for patients with overactive bladder (OAB); however, this approach is contrary to ...

THURSDAY, Jan. 2, 2025 (HealthDay News) -- Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy ...

Desmopressin is used in children with nocturnal enuresis, and it has recently shown some promise in the treatment of OAB in adults. Desmopressin is a synthetic analogue of vasopressin and thus ...

(HealthDay News) — Gemtesa (vibegron) has been approved by the US Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy for benign prostatic ...

THURSDAY, Jan. 2, 2025 (HealthDay News) — Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms receiving pharmacologic therapy ...

Acupuncture shows promise in reducing overactive bladder symptoms ... Cognitive behavioral therapy addresses psychological aspects of bladder control issues. This approach helps individuals ...

The most common symptom of an overactive bladder is a sudden, uncontrolled need or urge to urinate; followed by the need to urinate excessively throughout the day and night, independent of fluid ...

For the first time in over 25 years (since the approval of oxybutynin in 1972), better medications are available for the overactive bladder ... XL as the first-line therapy.

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...